 The increasing prevalence of chronic disorders, increasing technological advancements in the assay kits and analyzers, and increasing research in the field of vaccines are expected to be the primary factors affecting the ELISpot and Fluorospot Assay market. New York, March 24, 2020 GLOBE NEWSWIRE 